Advertisement

Monitoring Heparin Prophylaxis

  • J. G. Sharnoff

Abstract

The monitoring of heparin prophylaxis has long been a problem. As a result, many tests have been devised but have proved unsatisfactory for one reason or another. It was shortly before the discovery of heparin by McLean in 1916 that the Lee-White coagulation time test (1913) for blood was introduced and later used to determine the effect of heparin on coagulation. In general blood coagulation time has for many years been relied upon as the best method available. The test is performed by drawing 3 ml of venous blood in a dry glass syringe. With the needle removed, 1 ml of blood is delivered into three test tubes of standard size, 13 × 100 mm. A stopwatch is started when the blood is drawn into the syringe. The tubes are placed in a water bath at 37°C and after 2 minutes tilted every 30 seconds. When clotting is noted in each tube the times are recorded and their average is reported as the coagulation time; the normal range is 5–10 minutes. The test is not precise chiefly because of the difficulty in determining the end-point and is therefore less than satisfactory. An equally unsatisfactory and little used test is the capillary tube test where fingertip blood is allowed to fill capillary glass tubes of 1 mm diameter and 5 cm length; a stopwatch is started and the tubes are broken every 30 seconds until a fibrin thread is seen between the broken ends. The normal range is 3–5 minutes.

Keywords

Partial Thromboplastin Time Activate Partial Thromboplastin Time Heparin Therapy Wound Haematoma Heparin Prophylaxis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barrowcliffe, T. W., Johnson, E. A. and Thomas, D. P. (1978). Antithrombin III and heparin. Br. Med. Bull., 34, 143PubMedGoogle Scholar
  2. 2.
    Basu, D., Gallus, A., Hirsh, J. and Cade, J. (1972). A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N. Engl. J. Med., 287, 324PubMedCrossRefGoogle Scholar
  3. 3.
    Bonnar, J. and Denson, K. W. E. (1973). Monitoring of heparin. Thromb. Diath. Haemorrh., 30, 471PubMedGoogle Scholar
  4. 4.
    Brozovic, M. and Bangham, D. R. (1975). Heparin structure, function and clinical implications. In Bradshaw, R. A. and Wessler, S. (eds.) Advances in Experimental Medicine and Biology, Vol. 52, pp. 163–79. (New York and London: Plenum Press)Google Scholar
  5. 5.
    Bull, M. H., Huse, W. M. and Bull, B. S. (1975). Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anaesthesiology, 43, 346CrossRefGoogle Scholar
  6. 6.
    Charnley, J. (1972). Prophylaxis of postoperative thromboembolism. Lancet, 2, 134PubMedCrossRefGoogle Scholar
  7. 7.
    Cooke, E. D., Lloyd, M. J., Bowcock, S. A. and Pilcher, M. F. (1976). Monitoring during low-dose heparin prophylaxis. N. Engl. J. Med., 294, 1066PubMedGoogle Scholar
  8. 8.
    Davis, J. J. (1975). Monitoring during low dose heparin prophylaxis. N. Engl. J. Med., 293, 776PubMedGoogle Scholar
  9. 9.
    Denson, K. W. E. and Bonnar, J. (1973). The measurement of heparin. A method based on the potentiation of antifactor Xa. Thromb. Diath. Haemorrh., 30, 471PubMedGoogle Scholar
  10. 10.
    deTakats, G. (1943). Heparin tolerance, a test of the clotting mechanism. Surg. Gynecol. Obstet., 77, 31Google Scholar
  11. 11.
    deTakats, G. (1971). Heparin tolerance revisited. Surgery, 70, 318Google Scholar
  12. 12.
    deTakats, G. (1977). Small-dose prophylactic heparin, does it prevent venous thrombosis? Mod. Med., 38Google Scholar
  13. 13.
    Genton, E. (1974). Guidelines for heparin therapy. Ann. Intern. Med., 89, 77Google Scholar
  14. 14.
    Gormsen, J. and Haxholdt, B. Fl. (1960). The heparin tolerance test and thromboembolic incidence in surgery. Acta Chir. Scand., 120, 121PubMedGoogle Scholar
  15. 15.
    Gruber, V. F., Duckert, F., Fridrich, R., Torhorst, J. and Rem, J. (1977). Prevention of postoperative thromboembolism by dextran 40, low doses of heparin and xantinol nicotinate. Lancet, 1, 207PubMedCrossRefGoogle Scholar
  16. 16.
    Kazmier, F. J. (1976). A significant interaction between metronidazole and warfarin. Mayo Clin. Proc., 5, 782Google Scholar
  17. 17.
    Koepke, J. A. (1975). The partial thromboplastin time in the C. A. P. survey program. Am. J. Clin. Pathol., 63, 990PubMedGoogle Scholar
  18. 18.
    Makarg, A. L. and Waterbury, V. (1977). The activated partial thromboplastin time as a monitor of heparin: a warning. Johns Hopkins Med. J., 140, 311Google Scholar
  19. 19.
    Mant, M. J., O’Brien, B. D., Thong, K. L., Hammond, G. W., Birtwhistle, R. V. and Grace, M. G. (1977). Hemorrhagic complications of heparin therapy. Lancet, 1, 1133PubMedCrossRefGoogle Scholar
  20. 20.
    Multicentre Trial (1975). Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet, 2, 45Google Scholar
  21. 21.
    Pachter, H. L. and Riles, T. S. (1977). Bleeding and wound complications in the surgical patient, a prospective randomized study. Ann. Surg., 186, 669PubMedCrossRefGoogle Scholar
  22. 22.
    Penner, J. A. (1974). Experience with a thrombin clotting time assay for measuring heparin activity. Am. J. Clin. Pathol., 61, 645PubMedGoogle Scholar
  23. 23.
    Poller, L., Thomson, J. H. and Yee, K. F. (1977). Stability studies on lyophilized reference thromboplastins for standardization of prothrombin times. Lancet, 2, 1019PubMedCrossRefGoogle Scholar
  24. 24.
    Prevention of venous thromboembolism in surgical patients by low dose heparin. (1977). Circulation, 55, 423AGoogle Scholar
  25. 25.
    Shapiro, G. A., Huntzinger, S. W. and Wilson, J. E. (1977). Variation among commercial activated partial thromboplastin time reagents in response to heparin. Am. J. Clin. Pathol., 67, 477PubMedGoogle Scholar
  26. 26.
    Sharnoff, J. G. (1963). An evaluation of the Dale and Laidlaw coagulometer in heparin control of thromboembolism. NY State Assoc. Pub. Hlth. Lab., 43, 10Google Scholar
  27. 27.
    Sharnoff, J. G. (1977). Low-dose or small-dose heparin. Lancet, 2, 1087PubMedCrossRefGoogle Scholar
  28. 28.
    String, S. T. and Barcia, P. J. (1975). Complications of small dose prophylactic heparinization. Am. J. Surg., 130, 570PubMedCrossRefGoogle Scholar
  29. 29.
    Sherry, S. (1971). Thrombosis prevention. N. Engl. J. Med., 284, 1324PubMedCrossRefGoogle Scholar
  30. 30.
    Soloway, H. B., Cornett, B. M. and Grayson, J. W. (1972). Comparison of various activated partial thrombo-reagents in the laboratory control of heparin therapy. Am. J. Clin. Pathol., 39, 587Google Scholar
  31. 31.
    Taberner, D. A., Poller, L., Burslem, R. W. and Jones, J. B. (1978). Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br. Med. J., 1, 272PubMedCrossRefGoogle Scholar
  32. 32.
    Teien, A. N. and Lie, M. (1975). Heparin assay in plasma. A comparison of five clotting methods. Thromb. Res., 7, 777PubMedCrossRefGoogle Scholar
  33. 33.
    Teien, A. N., Lie, M. and Abildgard, U. (1976). Assay of heparin in plasma using a chromagenic substance for activated factor X. Thromb. Res., 8, 413PubMedCrossRefGoogle Scholar
  34. 34.
    Thomas, D. P. (1977). Low-dose heparin. Lancet, 2, 1181PubMedCrossRefGoogle Scholar
  35. 35.
    Triplett, D. A., Harms, G. J. and Koepke, J. A. (1978). The effect of heparin in activated partial thromboplastin times. Am. J. Clin. Pathol., 70, 556PubMedGoogle Scholar
  36. 36.
    Wessler, S. and Gitel, S. (1976). Control of heparin therapy. Prog. Hemostas. Thromb., 3, 311Google Scholar
  37. 37.
    Yin, E. T., Wessler, S. and Butler, J. V. (1973). Plasma heparin, a unique practical submicrogram-sensitive assay. J. Lab. Clin. Med., 8, 298Google Scholar

Copyright information

© J. G. Sharnoff 1980

Authors and Affiliations

  • J. G. Sharnoff
    • 1
  1. 1.The Mount Vernon HospitalMount VernonUSA

Personalised recommendations